(Q54298509)

English

Overexpression of miR-221 is associated with aggressive clinicopathologic characteristics and the BRAF mutation in papillary thyroid carcinomas.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22855362

Overexpression of miR-221 is associated with aggressive clinicopathologic characteristics and the BRAF mutation in papillary thyroid carcinomas. (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22855362

1 reference

based on heuristic

inferred from title

author name string

Yi-Li Zhou

1

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22855362

Chao Liu

2

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22855362

Xuan-xuan Dai

3

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22855362

Xiao-Hua Zhang

4

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22855362

Ou-Chen Wang

5

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22855362

publication date

2 August 2012

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22855362

Medical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22855362

29

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22855362

5

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22855362

3360-3366

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22855362

https://scigraph.springernature.com/pub.10.1007/s12032-012-0315-8

0 references

Prognostic factors and therapeutic strategies for differentiated carcinomas of the thyroid

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

Oncomirs - microRNAs with a role in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

MicroRNA deregulation in human thyroid papillary carcinomas.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

The role of microRNA genes in papillary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

miR-146b is highly expressed in adult papillary thyroid carcinomas with high risk features including extrathyroidal invasion and the BRAF(V600E) mutation.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

BRAFV600E mutation and X-linked inhibitor of apoptosis expression in papillary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

BRAF mutation in thyroid cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

Role of NF-kappaB in thyroid cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

BRAFV600E mutation, TIMP-1 upregulation, and NF-κB activation: closing the loop on the papillary thyroid cancer trilogy.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

NF-kB and c-Jun induce the expression of the oncogenic miR-221 and miR-222 in prostate carcinoma and glioblastoma cells

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

Development of a microRNA-based molecular assay for the detection of papillary thyroid carcinoma in aspiration biopsy samples.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

Expression profiling of difficult-to-diagnose thyroid histologic subtypes shows distinct expression profiles and identify candidate diagnostic microRNAs

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

Presence of BRAF V600E in very early stages of papillary thyroid carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22855362

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Eicosanoid Regulation of Vascular Endothelial Growth Factor Expression and Angiogenesis in Microvessel Endothelial Cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/22855362

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12032-012-0315-8

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22855362

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22855362

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54298509&oldid=1414512966"